Homocamptothecin (hCPT) is a camptothecin (CPT) derivative with a seven-membered β-hydroxylactone E ring, which shows higher lactone stability and improves topoisomerase I (Topo I) inhibition activity. In an attempt to improve the antitumor activity of homocamptothecins, a series of 7-alkenyl-homocamptothecin derivatives was designed and synthesized based on a semisynthetic route starting from CPT. Most of the synthesized compounds exhibit higher cytotoxic activities on the A-549 tumor cell line than topotecan (TPT). Some compounds such as 2a and 2o show a broad in vitro antitumor spectrum and exhibit superior Topo I-inhibition activity.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbdv.201100195DOI Listing

Publication Analysis

Top Keywords

synthesis biological
4
biological evaluation
4
evaluation 7-alkenyl
4
7-alkenyl homocamptothecins
4
homocamptothecins potent
4
potent topoisomerase
4
topoisomerase inhibitors
4
inhibitors homocamptothecin
4
homocamptothecin hcpt
4
hcpt camptothecin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!